#USA #Phoenix #MolecuLight #fluorescence imaging #Burn Care

MolecuLight's Role in Advancing Burn Treatment

MolecuLight Inc., a leader in medical imaging technology, is set to exhibit at the 2025 Annual Meeting of the American Burn Association (ABA) in Phoenix, Arizona, from April 8 to 11. This event is a platform for medical professionals to explore the latest innovations in burn care and wound management, and MolecuLight's participation underscores its commitment to improving patient outcomes through advanced imaging solutions.

Groundbreaking Imaging Technology

The highlight of MolecuLight’s showcase will be its state-of-the-art fluorescence imaging systems, the MolecuLight iX® and MolecuLight DX™, designed specifically for rapid bacterial detection in wounds. These are the only class II FDA-cleared imaging devices that provide real-time visualization of the bacterial burden, enabling clinicians to make informed decisions quickly and efficiently.

Attendees at the ABA meeting will have the opportunity to see these tools in action and understand how they can enhance the treatment of burn victims. Both devices allow for immediate, non-invasive imaging that reveals bacterial activity under the skin, which can be crucial for optimizing burn care.

Expert Insights and Presentations

One of the key attractions will be presentations by leading experts in the field. Dr. Erik Hanson-Viana, a plastic and reconstructive surgeon associated with Hospital Angeles in Mexico City, will deliver a podium presentation on April 9 at 11:45 AM. His talk, titled "Fluorescence Imaging-Guided Sampling Provides More Accurate and Actionable Microbiology Compared to the Levine Technique," will highlight how using the MolecuLight system improves the accuracy of sampling during burn reconstruction surgeries. Dr. Hanson-Viana’s findings demonstrate a clear advantage in graft timing and site selection over traditional methods, which have been less precise.

Alongside him, Dr. Carlos Daniel Torres García will present his award-winning research on the correlation between bacterial fluorescence signals and dermal regeneration template infections in burn patients on the same day at 12:30 PM. His work, which received acclaim at the recent Mexican National Plastic Surgery Congress, reinforces the importance of understanding bacterial loads to prevent complications in burn healing processes.

Engage with Innovators

Participants at the ABA meeting are encouraged to visit MolecuLight's booth (#626) for hands-on demonstrations. Here, they will be able to interact with Dr. Hanson-Viana and other representatives, receive live demonstrations of the imaging systems, and engage in discussions about their application in clinical settings. The real-time data provided by the MolecuLight systems can lead to more precise interventions, which ultimately improves outcomes for patients suffering from severe burns.

Conclusion

MolecuLight's innovative contributions to burn care are set to revolutionize the approach to wound management in clinical practices. By providing greater insight into bacterial presence and activity, these imaging technologies not only enhance healing but also pave the way for more targeted and effective interventions. With its presence at the ABA 2025 meeting, MolecuLight is poised to inspire and equip burn care professionals with vital tools needed for better patient care.

For more information on MolecuLight and its products, please visit www.moleculight.com.